< Back to Article

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175

Table 5

Geometric Mean Titre (GMT) at 95% Cl PfMSP-1₁₉-specific antibodies elicited after vaccination with 10μg, 25μg and 50μg JAIVAC-1 and Hepatitis B vaccine.

doi: https://doi.org/10.1371/journal.pone.0117820.t005